Thursday, December 12, 2019 11:11:55 AM
Some known catalysts include Daimler Mercedes Benz financing (in addition to the asset-based financing that Viola is seeking) and a manufacturing/cross-marketing deal for a patented APU system created by the operational principal of Payless.
There has been little to no dilution since the R/S. The last increase occurred in October. 25.5M+ O/S. Expecting an S-1 to spin-off the equity in Payless at some point where DCAC shareholders of record will receive a dividend.
$DCAC
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM